Page last updated: 2024-09-03

sch 23982 and apomorphine

sch 23982 has been researched along with apomorphine in 2 studies

Compound Research Comparison

Studies
(sch 23982)
Trials
(sch 23982)
Recent Studies (post-2010)
(sch 23982)
Studies
(apomorphine)
Trials
(apomorphine)
Recent Studies (post-2010) (apomorphine)
87009,205287780

Protein Interaction Comparison

ProteinTaxonomysch 23982 (IC50)apomorphine (IC50)
Tryptophan 5-hydroxylase 1Rattus norvegicus (Norway rat)0.22
D(2) dopamine receptorHomo sapiens (human)0.0146
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)7.75
DRattus norvegicus (Norway rat)0.4744
D(3) dopamine receptorRattus norvegicus (Norway rat)0.1432
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.063
D(2) dopamine receptorBos taurus (cattle)0.3385
D(1A) dopamine receptorHomo sapiens (human)0.025
D(4) dopamine receptorHomo sapiens (human)0.025
D(1B) dopamine receptorHomo sapiens (human)0.025
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.063
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.063
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)7.75
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.1432
D(4) dopamine receptorRattus norvegicus (Norway rat)0.1432
D(3) dopamine receptorHomo sapiens (human)0.025
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)7.75
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0813
E3 ubiquitin-protein ligase Mdm2Homo sapiens (human)0.205
5-hydroxytryptamine receptor 4 Rattus norvegicus (Norway rat)1.35
DBos taurus (cattle)0.3385

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, EF; Fahlbusch, R; Nomikos, P; Reif, M; Schrell, UM1
Ackerman, M; Artman, LD; Asin, KE; Bednarz, L; Johnson, MC; Kebabian, JW; Kerkman, DJ; MacKenzie, RG; Montana, W; Stampfli, H1

Other Studies

2 other study(ies) available for sch 23982 and apomorphine

ArticleYear
Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 71, Issue:6

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Apomorphine; Benzazepines; Binding, Competitive; Bromocriptine; Butaclamol; Cell Division; Dopamine; Dopamine Agents; Humans; Meningioma; Receptors, Dopamine; Receptors, Dopamine D1; Tumor Cells, Cultured

1990
A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor.
    European journal of pharmacology, 1989, Aug-03, Volume: 166, Issue:3

    Topics: Adenylyl Cyclases; Animals; Apomorphine; Benzazepines; Binding, Competitive; Catalepsy; Dihydroxyphenylalanine; Haloperidol; Injections, Subcutaneous; Iodine Radioisotopes; Male; Motor Activity; Papaverine; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Tetrahydroisoquinolines

1989